| Ytd | -16.40% | |
| 1y | 20.04% |
| Open | 130.90 | Prev Close | 145.49 | Low | 129.00 | High | 137.51 | Mkt Cap | 7.73B |
| Vol | 2.03M | Avg Vol | 1.16M | EPS | 1.80 | P/E | 76.11 | Forward P/E | 72.99 |
| Beta | 1.06 | Short Ratio | 5.46 | Inst. Own | 120.82% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 129.02 | 200-d Avg | 140.12 | 1yr Est | 177.05 |
RGEN News
Repligen Corp said on Wednesday it would buy BioLife Solutions in a cash-and-stock deal valued at
Fast-tracks Repligen's leadership and customer solution offering in high-growth cell therapy market
Semiconductors led a broad rebound Tuesday as Micron, Western Digital and Sandisk surged. Nasdaq 100
Webcast and Conference Call to Be Held Tuesday, July 28, 2026, at 8:00 a.m. ET Webcast and Conferenc
Benchmark analyst Robert Wasserman upgrades Repligen (NASDAQ:RGEN) from Hold to Buy and announces
Evercore ISI Group analyst Daniel Markowitz maintains Repligen (NASDAQ:RGEN) with a Outperform an
Tuesday's session saw 729 companies set new 52-week lows.
Before 10 a.m. ET on Thursday, 91 companies hit new 52-week highs.
Thursday's morning session saw 73 companies set new 52-week highs.
Companies Reporting Before The Bell • Mastercard Inc. (NYSE:MA) is expected to report quarterly ear